Mad Hedge Biotech and Healthcare Letter January 8, 2026 Fiat Lux Featured Trade: (YOU’LL WANT TO LEAVE BEFORE YOU SHOULD) (ABBV)
Author Archives: april@madhedgefundtrader.com
I remember landing in Tokyo years ago after a brutal trans-Pacific flight, the kind where your body shows up but your brain is still circling somewhere over the Aleutians. It was raining hard, my hotel in Shinjuku was wrapped in scaffolding, and the front desk politely explained that my room wouldn’t be ready for hours. […]
Global Market Comments January 8, 2026 Fiat Lux Featured Trades: (THE NEXT COMMODITY SUPER CYCLE HAS ALREADY STARTED), (COPX), (GLD), (FCX), (BHP), (RIO), (SIL), (PPLT), (PALL), (GOLD), (ECH), (EWZ), (IDX)
When I closed out my position in Freeport McMoRan (FCX) near its max profit this week, I received a hurried email from a reader if he should still keep the stock. I replied very quickly: “Hell, yes!” When I toured Australia a couple of years ago, I couldn’t help but notice a surprising number of […]
Mad Hedge Technology Letter January 7, 2026 Fiat Lux Featured Trade: (HUANG PUSHES THE AI STORY) (NVDA)
Now tech CEOs are making these brazen forecasts that will force investors to bet the ranch on the technology or be left behind. Outspoken tech CEOs do their bit to move along the narrative, and no other than Nvidia CEO Jensen Huang was the latest to puff up the AI revolution. CEO Jensen Huang’s audacious […]
07
Jan
Jan
“Software is eating the world, but AI is going to eat software.” – Said CEO of Nvidia Jensen Huang
THE EXPLOSIVE RALLY IN SILVER – IS IT OVER? January 7, 2026 Hello everyone Silver rocketed up to around $79 per ounce in 2025, which amounted to almost a 170% move, breaking the 45-year-old resistance level of $50. But what is fuelling this strong rally in silver? Let’s dig deeper. Persistent […]
Mad Hedge Biotech and Healthcare Letter January 6, 2026 Fiat Lux Featured Trade: (TURNS OUT, THE CURE WAS THE EASY PART) (CRSP), (SANA), (BEAM), (NTLA), (PRME), (DTIL)
I met a young woman in Geneva last year. Mid-20s, poised, bright. She had sickle cell disease and told me her childhood had been a blur of hospital beds and missed school years. Then she mentioned something I didn’t expect. She was part of a Casgevy clinical trial. No crises in over two years. She […]